About this episode
The episode discusses the integration of Europe's science and venture ecosystem with insights from industry experts.
In this episode of Denatured, you'll be hearing from Edoardo Negroni, co-founder & managing partner at AurorA-TT and Naveed Siddiqi, senior partner, Venture Investments at Novo Holdings. We debate whether Europe’s world-class science can be matched by a truly integrated venture ecosystem—and what it would take, in practice, to get there. Host Jennifer C. Smith-Parker , Director of Insights, BioSpace Guests Edoardo Negroni , Co-Founder & Managing Partner, AurorA-TT Naveed Siddiqi , Senior Partner, Venture Investments, Novo Holdings Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.
People in this episode
Host: Jennifer C. Smith-Parker
Guests: Edoardo Negroni, Naveed Siddiqi
Topics covered
- European biotech
- venture ecosystem
- funding
- science
- biotechnology
Keywords
- European biotech
- venture capital
- funding
- biotechnology
- AurorA-TT
- Novo Holdings
Mentioned in this episode
Organizations: AurorA-TT, Novo Holdings, BioSpace
More episodes of BioSpace
- Portugal, Spain and the new biotech frontier · June 10, 2026 · 21 min
- Lilly tees off with Novo at ADA, GSK’s $10.6B deal, FDA reform continues in Makary’s absence · June 10, 2026 · 25 min
- Rethinking hair loss treatment · June 3, 2026 · 22 min
- ASCO wins from RevMed, Akeso/Summit, more; plus more Lilly and more China; ADA on deck · June 3, 2026 · 27 min
- France’s biotech ecosystem: science, capital and scale · May 28, 2026 · 21 min
- Lilly wheels and deals, Moderna gets boost on hantavirus scare, ASCO excitement builds · May 27, 2026 · 25 min
Explore listener stats, chart rankings, contacts and more on the BioSpace podcast page.